TherapeuticsMD is a specialty pharmaceutical company focused on the sales,
marketing and development of branded and generic pharmaceutical and overthe-counter
(OTC) products for the women’s health market. In 2012 the
Company launched six prescription prenatal vitamins and announced the
funding of pharmacokinetic (PK) trials required before it can begin Phase III
trials on its three investigational new drugs (INDs) for hormone replacement
therapy (HRT) that were accepted by the FDA.